Reduced β‑Nicotinamide Mononucleotide (β‑NMNH);108347‑85‑9;99%

Product description

CAS: 108347-85-9 | Purity: ≥99% | Formula: C11H17N2O8P (MW: 336.23)Appearance: White powder | Solubility: Freely soluble in water | Packaging: 1 kg/bag, 25 kg/drum

β-NMNH (Reduced β-Nicotinamide Mononucleotide) is the reduced form of β-NMN and an advanced, next-generation NAD+ precursor. Research indicates β-NMNH exhibits superior potency in elevating intracellular NAD+ levels compared with conventional precursors, supporting cellular vitality and mitochondrial integrity.

• Next-Gen Precursor: Exceptional potential for intracellular NAD+ replenishment• Core Functions: Cellular energy metabolism, mitochondrial maintenance, fatigue recovery, and metabolic health• Target Applications: Anti-aging formulations, sports nutrition, premium longevity blends, and functional foods• Quality & Consistency: High-purity active powder with strict batch testing, stable solubility, and verified COA• Services: Custom ODM/OEM formulation, sample testing, and flexible bulk supply

Meet us at SupplySide Global 2026 (Booth: 6037-3).View product details & request samples:https://www.hygieiabiotech.com/product/nmnh-powder/
Read more

More products from Chengdu Hygieia Biotech Co.Ltd.

View all our products (12)

Products from other suppliers

Reduced β‑Nicotinamide Mononucleotide (β‑NMNH);108347‑85‑9;99%

Contact information

Address

Email

Telephone

Website

View all contact information